Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07355231) titled 'Lung Functional Avoidance Radiotherapy Using Hyperpolarized Xenon MRI' on Jan. 19.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).

Primary Sponsor: Xemed LLC

Condition: Carcinoma, Non-Small-Cell Lung

Intervention: Combination Product: Hyperpolarized xenon MRI

Recruitment Status: Not recruiting

Phase: Phase 1/Phase 2

Date of First Enrollment: March 1, 2026

Target Sample Size: 10

To know more, visit https://clinicaltrials.gov/study/NCT07355231

Disclaimer: Curated by HT Syndication....